Several corporates backed a $68m series D round for microbiome drug developer Vedanta Biosciences while grooming brand owner Pangaea raised the same amount from investors including Unilever.
Month: July 2021
The Global Corporate Venturing Powerlist 2021
Congratulations to all the thousands of nominees for the Global Corporate Venturing Powerlist 2021 and especially to the top 100 who gave their appreciation to their teams and portfolio companies in yesterday’s award ceremony.
CloudWalk gets the nod for IPO
The Bohai, Haier and PCI-Suntek-backed facial recognition technology developer has been approved to float on Shanghai’s Star Market in a $574m offering.
Cloudwise gathers $150m in funding
SIG has returned to back the IT operations software provider’s series E round, some seven months after its series D3 round.
SmartRecruiters secures $110m in series E funding
The Salesforce-backed recruitment managemeent software provider was valued at $1.5bn in a round that pushed its overall funding past $200m.
TMRW taps GV for $105m series C
TMRW Life Sciences is eyeing a global expansion of its frozen egg and embryo management services with new capital from investors including GV.
Employment Hero collects $103m
Seek and Salesforce Ventures helped the human resources software provider raise cash in a series E round led by Insight Partners at a $568m valuation.
OpenSea captures $100m at $1.5bn valuation
The NFT marketplace, which counts Coinbase, Animoca Brands and Gumi as investors, raised the funding in a series B round led by Andreessen Horowitz.
IsoPlexis applies itself to IPO filing
Danaher is in line to exit proteomics platform developer IsoPlexis in a Nasdaq Global Market offering with a $100m placeholder target.
PacBio to pick up Omniome in $800m deal
Nan Fung and Lam Research are set to exit the DNA sequencing technology developer in an $800m acquisition by market peer Pacific Biosciences.
Panakès holds $180m first close for Fund II
Panakès Partners is now targeting a final close upwards of $210m for its Purple Fund, which has reached its Menarini-backed first close.
Mural lures investors for $50m
Insight Partners and Tiger Global Management co-led a series C round valuing the Google, Slack and Intel-backed collaboration software provider above $2bn.
The world is losing one of its most powerful tools in healthcare: antibiotics
The reason is rapidly rising antibiotic-resistant infections – also called antimicrobial resistance (AMR), as noted in the latest report by the Wellcome Trust in the UK.
Daily Deal Round Up: July 21, 2021
6 Dimensions Capital-backed neuromodulation technology developer Neuspera closed a $65m round while gene therapy developer Coave Therapeutics hiked its latest round to $39m.